http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004110417-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ddf87d85caa4ee9b02b15fb2cf1ed34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05b9e1b987927fe34f6d59bb094014f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
filingDate 2004-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314b2d828f76852e8367499cd4384a41
publicationDate 2005-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004110417-A3
titleOfInvention Compositions for the enhanced treatment of depression
abstract For treatment of endogenous depression, there is taken in combination an antidepressant, particularly an SSRI or SNRA, and a precursor or inducer of a neurotransmitter, e.g. L-phenylalanine, tyramine or L-tryptophan. Optionally, the patient also takes vitamin B12.
priorityDate 2003-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03049687-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6096317-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6200607-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1112693-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0185165-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002078463-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5610

Total number of triples: 39.